Skip to content
Logo_terraplasma_medical_2x
Facebook Linkedin Youtube Envelope
  • Shop
  • EnglishEnglish
    • DeutschDeutsch
    • EnglishEnglish
  • Shop
  • EnglishEnglish
    • DeutschDeutsch
    • EnglishEnglish
  • Anwendungsbereiche
    • Wundbehandlung
    • Dermatologie
  • Technologie
    • Was ist Kaltplasma?
    • Geräte und Anwendung
    • Patente und Lizenzen
  • Wissen
    • Fachportal
    • Literatur
    • FAQ
  • Über uns
    • Karriere
    • Unser Team
    • Aktuelles
    • Veranstaltungen
    • Vertriebspartner
Menu
  • Anwendungsbereiche
    • Wundbehandlung
    • Dermatologie
  • Technologie
    • Was ist Kaltplasma?
    • Geräte und Anwendung
    • Patente und Lizenzen
  • Wissen
    • Fachportal
    • Literatur
    • FAQ
  • Über uns
    • Karriere
    • Unser Team
    • Aktuelles
    • Veranstaltungen
    • Vertriebspartner
Kontakt
  • Anwendungsbereiche
    • Wundbehandlung
    • Dermatologie
  • Technologie
    • Was ist Kaltplasma?
    • Geräte und Anwendung
    • Patente und Lizenzen
  • Wissen
    • Fachportal
    • Literatur
    • FAQ
  • Über uns
    • Karriere
    • Unser Team
    • Aktuelles
    • Veranstaltungen
    • Vertriebspartner
  • Kontakt
Menu
  • Anwendungsbereiche
    • Wundbehandlung
    • Dermatologie
  • Technologie
    • Was ist Kaltplasma?
    • Geräte und Anwendung
    • Patente und Lizenzen
  • Wissen
    • Fachportal
    • Literatur
    • FAQ
  • Über uns
    • Karriere
    • Unser Team
    • Aktuelles
    • Veranstaltungen
    • Vertriebspartner
  • Kontakt
Read more about the article Study in preparation for FDA approval successfully started

Study in preparation for FDA approval successfully started

  • Post author:a.islinger
  • Post published:25. July 2023
  • Post category:corporate/plasma care/press release

While patients with chronic wounds in Germany and other parts of Europe have been able to benefit from the effect of cold atmospheric plasma for some time now, medical cold…

Continue ReadingStudy in preparation for FDA approval successfully started
Read more about the article Strong distribution partner for the GCC countries

Strong distribution partner for the GCC countries

  • Post author:a.islinger
  • Post published:10. July 2023
  • Post category:corporate/plasma care/press release

Press release Garching July 10th, 2023 Cold plasma therapy will revolutionize therapy for chronic wound patients in GCC countries. Today the exclusive distribution cooperation between terraplasma medical and BSM Binary…

Continue ReadingStrong distribution partner for the GCC countries
Read more about the article New hope for several million patients with open wounds in Eastern Europe

New hope for several million patients with open wounds in Eastern Europe

  • Post author:a.islinger
  • Post published:6. April 2023
  • Post category:corporate/press release

terraplasma medical announces the exclusive sales cooperation for the distribution of the plasma care® product line in Eastern Europe.

Continue ReadingNew hope for several million patients with open wounds in Eastern Europe
We are taking off! A journey into the world of cold plasma

We are taking off! A journey into the world of cold plasma

  • Post author:s.gronwald
  • Post published:27. June 2022
  • Post category:corporate

Scientists at the Max Planck Institute for Extraterrestrial Physics in Garching have succeeded in recreating sun-hot plasma on Earth - and at hand-warm temperatures. We can use this so-called cold…

Continue ReadingWe are taking off! A journey into the world of cold plasma
Takeover of terraplasma medical GmbH by the Viromed Group

Takeover of terraplasma medical GmbH by the Viromed Group

  • Post author:s.gronwald
  • Post published:12. May 2022
  • Post category:corporate

Today, the majority takeover of terraplasma medical GmbH by Viromed Plasma GmbH, a company of the Viromed Group, was announced. terraplasma GmbH will continue to be a partner in terraplasma…

Continue ReadingTakeover of terraplasma medical GmbH by the Viromed Group

News

  • The future of wound therapy: testing of medical cold plasma brings new hope for patients with chronic wounds
  • An exclusive sales cooperation agreement between terraplasma medical GmbH and GD Medical has been signed.
  • Innovative partnership for advanced wound care: Wundgruppe24 and Viromed Medical GmbH enter into sales cooperation
  • Study in preparation for FDA approval successfully started
  • Strong distribution partner for the GCC countries
Logo_terraplasma_medical_2x

terraplasma medical GmbH
Parkring 32
D-85748 Garching bei München

Tel: +49 89 5880 553-0

info@terraplasma-medical.com

Anwendungsbereiche

Wundbehandlung
Dermatologie

Über uns

Karriere
Unser Team
Aktuelles
Veranstaltungen
Vertriebspartner

Weitere Informationen

Was ist Kaltplasma?
Technik
Patente & Lizenzen
FAQ
Facebook Linkedin Youtube Envelope
  • Impressum
  • Datenschutz
Manage cookie consent
We use cookies to optimise our website and our service.
provide admin functions Always active
Technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a particular service explicitly requested by the subscriber or user or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that have not been requested by the subscriber or user.
Statistics
The technical storage or access, which is solely for statistical purposes. Technical storage or access used solely for anonymous statistical purposes. Without a subpoena, voluntary consent from your Internet service provider, or additional records from third parties, information stored or accessed for this purpose cannot generally be used alone to identify you.
Marketing
Technical storage or access is necessary to create user profiles, to send advertising or to track the user on a website or across multiple websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
Preferences
{title} {title} {title}